Peter Evan Harwin, Director, 10% Owner at Dianthus Therapeutics, Inc. /DE/ (DNTH), bought 49,340 shares at $13.63 ($673K) on 2023-09-29, disclosed to the SEC on 2023-10-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.63 | 24,670 | $336K | 50.0% |
| 2 | $13.63 | 24,670 | $336K | 50.0% |
| Total | $13.63 avg | 49,340 | $673K | 100% |
| Filing → |
| ZBIO | BUY | 2025-10-09 | $6.0M | — | Filing → |
| ZBIO | BUY | 2024-09-16 | $5.1M | — | Filing → |